Rotavirus-Like Particles: A Novel Nanocarrier for the Gut

<table>Complete or incomplete VLP delivery to the normal or inflamed gut. Delivery of GFP (a) and viral proteins (b) to the colon and of viral proteins to the ileum (c) from healthy and TNBS-treated mice (<svg height="10.8125" id="M37" style="vertical-align:-0.10033pt" version="1.1" viewbox="0 0 35.099998 10.8125" width="35.099998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,10.8125)">
<g transform="translate(72,-63.35)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">4</tspan>
</text>
</g>
</g>
</svg>) was evaluated by ELISA assays. Results are expressed as absorbance units and are the mean <svg height="9.3249998" id="M38" style="vertical-align:-1.09097pt" version="1.1" viewbox="0 0 10.825 9.3249998" width="10.825" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,9.325)">
<g transform="translate(72,-64.54)">
<text transform="matrix(1,0,0,-1,-71.95,65.67)">
<tspan style="font-size: 12.50px; " x="0" y="0">±</tspan>
</text>
</g>
</g>
</svg> sd of three experiments. Dunnett’s test was used to compare treatments with the control group. </table>

BioMed Research International

Rotavirus-Like Particles: A Novel Nanocarrier for the Gut

Figure 7